Target
Cannabinoid receptor 2
Ligand
BDBM300137
Substrate
n/a
Meas. Tech.
cAMP Assay
EC50
1.60±n/a nM
Citation
 Grether, UNettekoven, MRogers-Evans, MRoever, SSchmitt, SKimbara, A Triazolo[4,5-D]pyrimidine derivatives US Patent  US9593123 Publication Date 3/14/2017 
Target
Name:
Cannabinoid receptor 2
Synonyms:
CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
39690.94
Organism:
Homo sapiens (Human)
Description:
P34972
Residue:
360
Sequence:
MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTASVGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCSELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLDVRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYALRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
  
Inhibitor
Name:
BDBM300137
Synonyms:
5-(Azetidin-1-yl)-3-[(2-chlorophenyl)methyl]-7-(3,3-difluoropyrrolidin-1-yl)triazolo [4,5-d]pyrimidine | US9593123, Example 9
Type:
Small organic molecule
Emp. Form.:
C18H18ClF2N7
Mol. Mass.:
405.832
SMILES:
FC1(F)CCN(C1)c1nc(nc2n(Cc3ccccc3Cl)nnc12)N1CCC1
Structure:
Search PDB for entries with ligand similarity: